ENTRY       K04813                      KO
NAME        CHRNB2
DEFINITION  nicotinic acetylcholine receptor beta-2
PATHWAY     ko04080  Neuroactive ligand-receptor interaction
            ko04725  Cholinergic synapse
            ko05033  Nicotine addiction
DISEASE     H00807  Autosomal dominant nocturnal frontal lobe epilepsy (ADNFLE)
BRITE       KEGG Orthology (KO) [BR:ko00001]
             Environmental Information Processing
              Signaling molecules and interaction
               04080 Neuroactive ligand-receptor interaction
                K04813  CHRNB2; nicotinic acetylcholine receptor beta-2
             Organismal Systems
              Nervous system
               04725 Cholinergic synapse
                K04813  CHRNB2; nicotinic acetylcholine receptor beta-2
             Human Diseases
              Substance dependence
               05033 Nicotine addiction
                K04813  CHRNB2; nicotinic acetylcholine receptor beta-2
            Ion channels [BR:ko04040]
             Cys-loop superfamily
              Acetylcholine (nicotinic)
               K04813  CHRNB2; nicotinic acetylcholine receptor beta-2
DBLINKS     GO: 0015464
            TC: 1.A.9.1
GENES       HSA: 1141(CHRNB2)
            PTR: 740303(CHRNB2)
            PPS: 100971342(CHRNB2)
            GGO: 101135472(CHRNB2)
            PON: 100462523(CHRNB2)
            MCC: 716830(CHRNB2)
            MCF: 101925131
            MMU: 11444(Chrnb2)
            RNO: 54239(Chrnb2)
            CGE: 100761068(Chrnb2)
            HGL: 101704220(Chrnb2)
            TUP: 102484767(CHRNB2)
            CFA: 490443(CHRNB2)
            AML: 100470525(CHRNB2)
            FCA: 101084932(CHRNB2)
            PTG: 102950491(CHRNB2)
            BTA: 517519(CHRNB2)
            BOM: 102288290(CHRNB2)
            PHD: 102339057(CHRNB2)
            CHX: 102179250(CHRNB2)
            SSC: 100516491(CHRNB2)
            CFR: 102522958(CHRNB2)
            BACU: 103018933(CHRNB2)
            LVE: 103077541(CHRNB2)
            MYB: 102252199(CHRNB2)
            MYD: 102758614(CHRNB2)
            PALE: 102898876(CHRNB2)
            MDO: 100020783(CHRNB2)
            GGA: 395605(CHRNB2)
            MGP: 100542105
            TGU: 100223092(CHRNB2)
            FAB: 101808947(CHRNB2)
            PHI: 102105773(CHRNB2)
            CLV: 102086879(CHRNB2)
            ASN: 102370418(CHRNB2)
            AMJ: 102575673(CHRNB2)
            PSS: 102450194(CHRNB2)
            CMY: 102930008(CHRNB2)
            ACS: 100555506
            PBI: 103051135(CHRNB2)
            XLA: 495135(chrnb2)
            XTR: 100101688(chrnb2)
            DRE: 561906(chrnb2b)
            TRU: 446030(Fr_b5) 446088(Fr_b2) 446093(frb6)
            MZE: 101470192 101471024 101483619
            OLA: 101163178 101168846 101175346
            XMA: 102220186 102227551 102232696
            LCM: 102362930(CHRNB2)
            CMK: 103173104 103174390
            BFO: BRAFLDRAFT_195309 BRAFLDRAFT_217648 BRAFLDRAFT_217665 BRAFLDRAFT_77571
            CIN: 100180497(nachr)
REFERENCE   PMID:19279256
  AUTHORS   Lee WY, Free CR, Sine SM
  TITLE     Binding to gating transduction in nicotinic receptors: Cys-loop energetically couples to pre-M1 and M2-M3 regions.
  JOURNAL   J Neurosci 29:3189-99 (2009)
REFERENCE   PMID:15471911
  AUTHORS   Buccafusco JJ
  TITLE     Neuronal nicotinic receptor subtypes: defining therapeutic targets.
  JOURNAL   Mol Interv 4:285-95 (2004)
///
